Breakthrough in Migraine Care
PROVIDING SAFER AND MORE EFFECTIVE
MIGRAINE MEDICATION
OUR PHILOSOPHY
Seurat aims to stop migraines before they start.
Studies have shown that Environmental Enrichment, a naturally-induced biological phenomenon, can reduce brain diseases by half.
By replicating Environmental Enrichment through a therapeutic approach, we can not only stop migraines in their tracks but also prevent them in the future.
OUR STORY
Seurat Therapeutics sprung from the University of Chicago and is currently based at the Polsky Exchange. We are a team passionate about innovating migraine care and accelerating the translation of scientific discoveries into life-changing medicine.
OUR VISION
In the U.S., 1 out of 10 people suffer from migraines. Due to the lack of medicine that truly treat the cause of these migraines, patients are often left helpless and have to resort to bed rest for hours to days. Our mission is to give these people their lives back.
OUR APPROACH
The science behind Seurat Therapeutics is based on years of research from the University of Chicago medical center. Our treatment philosophy stems from a belief that novel neurotherapeutics based on EE can improve brain health.
OUR TEAM
MARTIN SANDERS, MD
Co-Founder
Chairman
YUAN ZHANG, PHD, MS
Co-Founder
CEO and President
SHARON LEW, MS
Chief Financial Officer
Scott Meadow, MBA
Board Member